Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme

By sjmartinez • June 13, 2023

Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, Yamaoka K, Richez C, Palac H, Dilley D, Liu J, Strengholt S, Burmester G. Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 Jun 12:ard-2023-223916. doi: 10.1136/ard-2023-223916. Epub ahead of print. PMID: 37308218.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, methotrexate, Publications, Rheumatology, tumor necrosis factor inhibitors

Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum

Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang[...]

Association between Alzheimer’s disease-related genes and neurodegenerative blood-based biomarkers in Indian adults

Abu-Amara H, Zhao W, Li Z, Leung YY, Schellenberg GD, Wang LS, Crimmins EM, Thyagarajan B, Anwar M, Hu P, Dey S, Dey AB, Zhou[...]

Metastatic Melanoma Presenting As Small Bowel Obstruction

Ruci A, Chan SM, Kan CK, Fagel C, Maque J. Metastatic Melanoma Presenting As Small Bowel Obstruction. Cureus. 2026 Aug 2;18(8):e113827. doi: 10.7759/cureus.113827. PMID: 42688324;[...]